AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review

Bulletin Express

08/14

AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.

The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).

The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1184965148"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184965148\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184965148?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 08:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184965148","market":"us","top_or_hot":-1,"title":"AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.</p>\n<p>The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).</p>\n<p>The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical to Convene 26 Aug 2026 Board Meeting for H1 Results and Interim Dividend Review\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-14 08:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.</p>\n<p>The meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).</p>\n<p>The company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"愛康醫療","start_time":0,"source_url":"","article_id":"1184965148","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184965148","pubTimestamp":1786665954,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"AK Medical 将于 2026 年 8 月 26 日召开董事会会议，审查上半年业绩和中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited (AK Medical) has scheduled a board meeting for 26 August 2026 at the Group’s Global Operation Center in Beijing. The agenda includes consideration and approval of the consolidated interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.\nThe meeting will be chaired by Chairman Li Zhijiang and attended by the full Board, comprising four executive Directors (Li Zhijiang, Zhang Bin, Zhang Chaoyang, Zhao Xiaohong), one non-executive Director (Dr. Wang David Guowei) and three independent non-executive Directors (Kong Chi Mo, Dr. Li Shu Wing David, Dr. Gao Wei).\nThe company’s announcement, released on 14 August 2026, emphasizes that any interim dividend decision will be contingent upon the Board’s review of the half-year financial performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}